Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Basic): 2019-2025

Historic EPS (Basic) for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -$1.16.

  • Biodesix's EPS (Basic) rose 17.14% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 331.58%. This contributed to the annual value of -$0.33 for FY2024, which is 48.44% up from last year.
  • Latest data reveals that Biodesix reported EPS (Basic) of -$1.16 as of Q3 2025, which was down 1,350.00% from -$0.08 recorded in Q2 2025.
  • Biodesix's EPS (Basic)'s 5-year high stood at $5.28 during Q4 2024, with a 5-year trough of -$1.40 in Q3 2024.
  • Over the past 3 years, Biodesix's median EPS (Basic) value was -$0.14 (recorded in 2024), while the average stood at $0.15.
  • Examining YoY changes over the last 5 years, Biodesix's EPS (Basic) showed a top increase of 5,966.67% in 2024 and a maximum decrease of 900.00% in 2024.
  • Biodesix's EPS (Basic) (Quarterly) stood at -$0.49 in 2021, then spiked by 32.65% to -$0.33 in 2022, then skyrocketed by 72.73% to -$0.09 in 2023, then spiked by 5,966.67% to $5.28 in 2024, then grew by 17.14% to -$1.16 in 2025.
  • Its last three reported values are -$1.16 in Q3 2025, -$0.08 for Q2 2025, and -$0.08 during Q1 2025.